Antinociceptive effect of bupivacaine encapsulated in poly(D,L)-lactide- co-glycolide microspheres in the acute inflammatory pain model of carrageenin-injected rats

Anesthesia and Analgesia

Volumn 84, Issue 1, 1997, Pages 90-94

  Fletcher, D ^a   Le Corre, P ^c   Guilbaud, G ^b   Le Verge, R ^c  

^a BICÊTRE HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; DRUG EFFECT; LOCAL ANESTHESIA; MICROENCAPSULATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

ACUTE DISEASE; ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; CARRAGEENAN; DRUG COMPOUNDING; INFLAMMATION; INJECTIONS, SUBCUTANEOUS; LACTIC ACID; MALE; MICROSPHERES; PAIN; PAIN MEASUREMENT; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031015347     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199701000-00017     Document Type: Article

References (14)

1. Cousins MJ, Bridenbaugh PO. Neural blockade in clinical anesthesia and management of pain. Philadelphia: JB Lippincott, 1988:734-91.
2. Cousins MJ. Clinical pharmacology of local anesthetic agents. In: Cousins MJ, Bridenbaugh PO, eds. Neural blockade in clinical anesthesia and management of pain. Philadelphia: JB Lippincott, 1988:111-44.
3. Le Corre P, Estebe JP, Chevanne F, et al. Spinal controlled delivery of bupivacaine from DL lactic acid oligomer micro spheres. J Pharm Sci 1995;84:75-8.
4. Estebe JP, Le Corre P, Chevanne F, et al. Prolongation du bloc sciatique chez le rat par encapsulation de bupivacaine dans des microspheres d'acide lactique [abstract]. Ann Fr Anesth Reanim 1994;13:R121.
5. Malinovsky JM, Bernard JM, Le Corre P, et al. Motor and blood pressure effects of epidural sustained release bupivacaine from polymer microspheres: a dose-response study in rabbits. Anesth Analg 1995;81:519-24.
6. Estebe JP, Le Corre P, Chevanne F, et al. Prolongation of spinal anesthesia with bupivacaine-loaded (DL)-lactide microspheres. Anesth Analg 1995;81:99-103.
7. Vinegar R, Schreiber W, Hugo R. Biphasic development of carrageenin oedema in rats. J Pharmacol Exp Ther 1969;166: 96-103.
8. Kayser V, Guilbaud G. Local and remote modifications of nociceptive sensitivity during carrageenin-induced inflammation in the rat. Pain 1987;28:99-107.
9. Committee for Research and Ethical Issues of the IASP. Ethical standards for investigations of experimental pain in animals. Pain 1983;16:109-10.
10. Kayser V, Guilbaud G. Differential effects of various doses of morphine and naloxone on two nociceptive test thresholds in arthritic and normal rats. Pain 1990;41:353-63.
11. Fletcher D, Kayser V, Guilbaud G. Influence of timing on the analgesic effect of bupivacaine infiltration in carrageenin injected rats. Anesthesiology 1996;84:1129-37.
12. Le Corre P, Le Guevello P, Gajan V, et al. Preparation and characterization of bupivacaine-loaded polylactide and polylactide-co-glycolide microspheres. Int J Pharm (Amst) 1994; 107:41-9.
13. Grant GJ, Vermeulen K, Langerman L, et al. Prolonged analgesia with liposomal bupivacaine in a mouse model. Reg Anaesth 1994;19:264-9.
14. Kuzma PJ, Kline MD, Boedecker BH, Haynes DH. Microcrystalline bupivacaine coated with lecithin produces ultra long duration local anesthesia in the rat tail [abstract]. Anesthesiology 1994;81:A1033.